Target intelligence / Profile preview

Ubiquitin-protein ligase E3A (UBE3A)

Target
UBE3A
Molecular classification
Enzyme, Ubiquitin ligase, HECT-type E3 ubiquitin ligase, Transcription factor
01

Overview

Ubiquitin-protein ligase E3A (UBE3A) is an enzyme that plays a central role in the ubiquitin–proteasome system, responsible for tagging proteins with ubiquitin for degradation. It is crucial for neuronal function, synaptic plasticity, and overall cellular homeostasis. Loss-of-function mutations in the maternally inherited UBE3A gene cause Angelman syndrome, while rare gain-of-function variants are associated with autism and intellectual disability. UBE3A also acts as a transcriptional coactivator. It regulates viral pathogenesis by targeting key viral proteins for degradation.

Other names
E6AP ubiquitin-protein ligaseE6-associated proteinE6-AP
02

Mechanism of action

Catalyzes the formation of K48-linked polyubiquitin chains on substrate proteins, targeting them for proteasomal degradation. Functions as a transcriptional coactivator for steroid hormone receptors.

03

Biological functions

Protein ubiquitinationProtein degradationSynaptic plasticity regulationNeuronal developmentTranscriptional coactivationRegulation of proteostasis
04

Disease associations

Angelman syndromeAutism spectrum disorderIntellectual disabilitySeizuresViral pathogenesis
05

Safety considerations

Gain-of-function variants can lead to neurological problemsImprinted expression pattern adds complexity to therapeutic targeting.

Beyond the preview

Go deeper on Ubiquitin-protein ligase E3A (UBE3A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-protein ligase E3A (UBE3A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call